Literature DB >> 22065502

Coronary artery disease in a Werner syndrome-like form of progeria characterized by low levels of progerin, a splice variant of lamin A.

Fuki M Hisama1, Davor Lessel, Dru Leistritz, Katrin Friedrich, Kim L McBride, Matthew T Pastore, Gary S Gottesman, Bidisha Saha, George M Martin, Christian Kubisch, Junko Oshima.   

Abstract

Classical Hutchinson-Gilford progeria syndrome (HGPS) is caused by LMNA mutations that generate an alternatively spliced form of lamin A, termed progerin. HGPS patients present in early childhood with atherosclerosis and striking features of accelerated aging. We report on two pedigrees of adult-onset coronary artery disease with progeroid features, who were referred to our International Registry of Werner Syndrome (WS) because of clinical features consistent with the diagnosis. No mutations were identified in the WRN gene that is responsible for WS, among these patients. Instead, we found two novel heterozygous mutations at the junction of exon 10 and intron 11 of the LMNA gene. These mutations resulted in the production of progerin at a level substantially lower than that of HGPS. Our findings indicate that LMNA mutations may result in coronary artery disease presenting in the fourth to sixth decades along with short stature and a progeroid appearance resembling WS. The absence of early-onset cataracts in this setting should suggest the diagnosis of progeroid laminopathy. This study illustrates the evolving genotype-phenotype relationship between the amount of progerin produced and the age of onset among the spectrum of restrictive dermopathy, HGPS, and atypical forms of WS.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22065502      PMCID: PMC4679285          DOI: 10.1002/ajmg.a.34336

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  17 in total

1.  Lamin a truncation in Hutchinson-Gilford progeria.

Authors:  Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Pierre Cau; Claire Navarro; Jeanne Amiel; Irène Boccaccio; Stanislas Lyonnet; Colin L Stewart; Arnold Munnich; Martine Le Merrer; Nicolas Lévy
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations.

Authors:  Katrin Friedrich; Lin Lee; Dru F Leistritz; Gudrun Nürnberg; Bidisha Saha; Fuki M Hisama; Daniel K Eyman; Davor Lessel; Peter Nürnberg; Chumei Li; María J Garcia-F-Villalta; Carolien M Kets; Joerg Schmidtke; Vítor Tedim Cruz; Peter C Van den Akker; Joseph Boak; Dincy Peter; Goli Compoginis; Kivanc Cefle; Sukru Ozturk; Norberto López; Theda Wessel; Martin Poot; P F Ippel; Birgit Groff-Kellermann; Holger Hoehn; George M Martin; Christian Kubisch; Junko Oshima
Journal:  Hum Genet       Date:  2010-05-05       Impact factor: 4.132

3.  Positional cloning of the Werner's syndrome gene.

Authors:  C E Yu; J Oshima; Y H Fu; E M Wijsman; F Hisama; R Alisch; S Matthews; J Nakura; T Miki; S Ouais; G M Martin; J Mulligan; G D Schellenberg
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

4.  The spectrum of WRN mutations in Werner syndrome patients.

Authors:  Shurong Huang; Lin Lee; Nancy B Hanson; Catherine Lenaerts; Holger Hoehn; Martin Poot; Craig D Rubin; Da-Fu Chen; Chih-Chao Yang; Heike Juch; Thomas Dorn; Roland Spiegel; Elif Arioglu Oral; Mohammed Abid; Carla Battisti; Emanuela Lucci-Cordisco; Giovanni Neri; Erin H Steed; Alexa Kidd; William Isley; David Showalter; Janet L Vittone; Alexander Konstantinow; Johannes Ring; Peter Meyer; Sharon L Wenger; Axel von Herbay; Uwe Wollina; Markus Schuelke; Carin R Huizenga; Dru F Leistritz; George M Martin; I Saira Mian; Junko Oshima
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

5.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

6.  Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganization and identify restrictive dermopathy as a lethal neonatal laminopathy.

Authors:  Claire L Navarro; Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Irène Boccaccio; Amandine Boyer; David Geneviève; Smail Hadj-Rabia; Caroline Gaudy-Marqueste; Henk Sillevis Smitt; Pierre Vabres; Laurence Faivre; Alain Verloes; Ton Van Essen; Elisabeth Flori; Raoul Hennekam; Frits A Beemer; Nicole Laurent; Martine Le Merrer; Pierre Cau; Nicolas Lévy
Journal:  Hum Mol Genet       Date:  2004-08-18       Impact factor: 6.150

7.  Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes.

Authors:  Casey L Moulson; Loren G Fong; Jennifer M Gardner; Emily A Farber; Gloriosa Go; Annalisa Passariello; Dorothy K Grange; Stephen G Young; Jeffrey H Miner
Journal:  Hum Mutat       Date:  2007-09       Impact factor: 4.878

8.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

Authors:  Robert D Goldman; Dale K Shumaker; Michael R Erdos; Maria Eriksson; Anne E Goldman; Leslie B Gordon; Yosef Gruenbaum; Satya Khuon; Melissa Mendez; Renée Varga; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

9.  Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development.

Authors:  Leslie B Gordon; Kathleen M McCarten; Anita Giobbie-Hurder; Jason T Machan; Susan E Campbell; Scott D Berns; Mark W Kieran
Journal:  Pediatrics       Date:  2007-10       Impact factor: 7.124

10.  Phenotype and course of Hutchinson-Gilford progeria syndrome.

Authors:  Melissa A Merideth; Leslie B Gordon; Sarah Clauss; Vandana Sachdev; Ann C M Smith; Monique B Perry; Carmen C Brewer; Christopher Zalewski; H Jeffrey Kim; Beth Solomon; Brian P Brooks; Lynn H Gerber; Maria L Turner; Demetrio L Domingo; Thomas C Hart; Jennifer Graf; James C Reynolds; Andrea Gropman; Jack A Yanovski; Marie Gerhard-Herman; Francis S Collins; Elizabeth G Nabel; Richard O Cannon; William A Gahl; Wendy J Introne
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

View more
  30 in total

Review 1.  Skin Disease in Laminopathy-Associated Premature Aging.

Authors:  Tomás McKenna; Agustín Sola Carvajal; Maria Eriksson
Journal:  J Invest Dermatol       Date:  2015-07-29       Impact factor: 8.551

2.  Truncated prelamin A expression in HGPS-like patients: a transcriptional study.

Authors:  Florian Barthélémy; Claire Navarro; Racha Fayek; Nathalie Da Silva; Patrice Roll; Sabine Sigaudy; Junko Oshima; Gisèle Bonne; Kyriaki Papadopoulou-Legbelou; Athanasios E Evangeliou; Martha Spilioti; Martine Lemerrer; Ron A Wevers; Eva Morava; Andrée Robaglia-Schlupp; Nicolas Lévy; Marc Bartoli; Annachiara De Sandre-Giovannoli
Journal:  Eur J Hum Genet       Date:  2015-02-04       Impact factor: 4.246

3.  POLD1 Germline Mutations in Patients Initially Diagnosed with Werner Syndrome.

Authors:  Davor Lessel; Fuki M Hisama; Katalin Szakszon; Bidisha Saha; Alexander Barrios Sanjuanelo; Bonnie A Salbert; Pamela D Steele; Jennifer Baldwin; W Ted Brown; Charles Piussan; Henri Plauchu; Judit Szilvássy; Edit Horkay; Josef Högel; George M Martin; Alan J Herr; Junko Oshima; Christian Kubisch
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

Review 4.  Hereditary Syndromes with Signs of Premature Aging.

Authors:  Davor Lessel; Christian Kubisch
Journal:  Dtsch Arztebl Int       Date:  2019-07-22       Impact factor: 5.594

Review 5.  Search and insights into novel genetic alterations leading to classical and atypical Werner syndrome.

Authors:  Junko Oshima; Fuki M Hisama
Journal:  Gerontology       Date:  2014-01-03       Impact factor: 5.140

Review 6.  How Research on Human Progeroid and Antigeroid Syndromes Can Contribute to the Longevity Dividend Initiative.

Authors:  Fuki M Hisama; Junko Oshima; George M Martin
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

7.  Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome.

Authors:  Leslie B Gordon; Joe Massaro; Ralph B D'Agostino; Susan E Campbell; Joan Brazier; W Ted Brown; Monica E Kleinman; Mark W Kieran
Journal:  Circulation       Date:  2014-05-02       Impact factor: 29.690

Review 8.  WRN Mutation Update: Mutation Spectrum, Patient Registries, and Translational Prospects.

Authors:  Koutaro Yokote; Sirisak Chanprasert; Lin Lee; Katharina Eirich; Minoru Takemoto; Aki Watanabe; Naoko Koizumi; Davor Lessel; Takayasu Mori; Fuki M Hisama; Paula D Ladd; Brad Angle; Hagit Baris; Kivanc Cefle; Sukru Palanduz; Sukru Ozturk; Antoinette Chateau; Kentaro Deguchi; T K M Easwar; Antonio Federico; Amy Fox; Theresa A Grebe; Beverly Hay; Sheela Nampoothiri; Karen Seiter; Elizabeth Streeten; Raul E Piña-Aguilar; Gemma Poke; Martin Poot; Renata Posmyk; George M Martin; Christian Kubisch; Detlev Schindler; Junko Oshima
Journal:  Hum Mutat       Date:  2016-10-07       Impact factor: 4.878

9.  Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann-Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations.

Authors:  Davor Lessel; Ayse Bilge Ozel; Susan E Campbell; Abdelkrim Saadi; Martin F Arlt; Keisha Melodi McSweeney; Vasilica Plaiasu; Katalin Szakszon; Anna Szőllős; Cristina Rusu; Armando J Rojas; Jaime Lopez-Valdez; Holger Thiele; Peter Nürnberg; Deborah A Nickerson; Michael J Bamshad; Jun Z Li; Christian Kubisch; Thomas W Glover; Leslie B Gordon
Journal:  Hum Genet       Date:  2018-11-19       Impact factor: 4.132

Review 10.  Werner syndrome: Clinical features, pathogenesis and potential therapeutic interventions.

Authors:  Junko Oshima; Julia M Sidorova; Raymond J Monnat
Journal:  Ageing Res Rev       Date:  2016-03-15       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.